Background/Aims: Haptoglobin (Hp) is a hemoglobin-binding acute phase
protein characterized by a genetic polymorphism due to the existence o
f two different alleles encoding for the alpha chain of the protein, T
hree phenotypes have been described: Hp 1-1, Hp 2-1 and Hp 2-2. The la
tter two forms are known to possess immunoglobulin-like properties and
play a role in the immune response, Recently, it has been shown that
in subjects suffering from hepatitis C, serum Hp concentrations were l
ower than in the reference population. In the present study we examine
d whether the haptoglobin phenotype distribution in chronic HCV patien
ts was different from the reference population. We also looked for pos
sible relationships between Hp phenotypes and hepatitis C virus types
and response to interferon a therapy. Moreover, Hp concentrations were
determined. Methods: The study population consisted of 239 Caucasian
patients with proven hepatitis C. Hp phenotypes were determined using
starch gel electrophoresis of hemoglobin-supplemented serum, followed
by peroxidase staining, Serum Hp concentrations were assayed with an i
mmunonephelometric method. Hepatitis C virus was genotyped accepted sy
stem, Two hundred and twenty healthy Caucasian blood-donors served as
the reference population. Results: In the reference population, 35 ind
ividuals (15.9%) had Hp 1-1, 106 persons (48.2%) had Hp 2-1 and 79 had
Hp 2-2 (35.9%), resulting in an Hp 1 allele frequency of 0.400, which
is in agreement with the Hardy-Weinberg equilibrium, Hp phenotype dis
tributions and Hp allele frequencies in the chronic hepatitis C virus
patient group differed significantly from those obtained in the refere
nce population, In the patient population, 59 individuals (24.7%) had
Hp 1-1, 112 persons (46.9%) had Hp 2-1 and 68 had Hp 2-2 (28.5%). This
resulted in an Hp 1 allele frequency of 0.481, which is in agreement
with the Hardy-Weinberg equilibrium, No statistically significant diff
erences were found between Hp phenotype distribution and hepatitis C v
irus types or response to interferon alpha therapy. Conclusions: The o
bserved shift in Hp phenotype distribution in chronic hepatitis C may
point to a role of Hp in the natural evolution of hepatitis C.